Vasa Therapeutics
Manufacturing · California, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
533 2nd St Ste 350, Encinitas, Californi...Website
www.vasatherapeutics.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
1
1
1
1
1
1
About Vasa Therapeutics
Based out of Encinitas, Vasa Therapeutics, is a biopharmaceutical company with a focus on cardiovascular aging.Explore more
Popular SearchesVasa TherapeuticsVasa Therapeutics IncSIC Code 28,283NAICS Code 32,325Show moreVasa Therapeutics Org Chart
Get the full picture
Sign in to uncover key details.
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Vasa Therapeutics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check if Vasa Therapeutics has recently received funding, and reach out quickly before it becomes old news!
Website visits: Recent activity has been detected on your website
Click to see if Vasa Therapeutics had a recent Job posting/layoffs
Product Launch: Get notified when Vasa Therapeutics launches new products
Vasa Therapeutics, which may be a good buyer, showed buying intent in Masked Content Topic
Congratulate Masked Content for being promoted to Masked Content at Vasa Therapeutics
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check out if Vasa Therapeutics is spiking on competitors!
Funding: Get notified immidiatlly once Vasa Therapeutics has new funding data
Earning: See what the market has to say on Vasa Therapeutics recently announced quarterly report
Recommended Actions
Reach out to Masked Content who joined Vasa Therapeutics as Masked Content
Find 3 more new buyers
Company Profile Activity
Activity Insights
Vasa Therapeutics is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Vasa Therapeutics is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Vasa Therapeutics.
Vasa Therapeutics financials insights
Gather financial insights about Vasa Therapeutics, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2024
Grant
$2.3M
Angel/Seed
$6M
Vasa Therapeutics Tech Stack
A closer look at the technologies used by Vasa Therapeutics
See more technologies
Most Recent Scoops
Project
Laboratory Operations, Medical Research, Clinical Operations
Project
Product Development, Research & Development, Safety, Medical Research, Pharmaceuticals, Clinical Operations, Regulations
Funding
Funding
Vasa Therapeutics News & Media
Vasa Therapeutics Announces Oral Presentation on VS-214 at the 2026 Vascular Discovery Meeting of American Heart Association
VS-214, a Long-Acting Apelin Agonist, Highlighted as a Potential First-in-Class Treatment for Peripheral Artery Disease ENCINITAS, Calif., May 11, 2026 /PRNewswire/ -- Vasa Therapeutics ("Vasa"), a clinical stage biotechnology company developing novel therapies for cardiovascular and...Vasa Therapeutics Partners with Lilly TuneLab to Power AI/ML-Driven CAMKII Inhibitor Platform
Vasa's CAMKII delta inhibitor, a leading discovery and development platform built on extensive crystallography data, will utilize Lilly TuneLab AI/ML predictive models to accelerate candidate selection. First-in-Human study planned for 2027. ENCINITAS, Calif., April 14, 2026 /PRNewswire/...Vasa Therapeutics Announces Participation at the 36th Annual Oppenheimer Life Sciences Conference
ENCINITAS, Calif. and WROCLAW, Poland, Feb. 12, 2026 /PRNewswire/ -- Vasa Therapeutics ("Vasa"), a clinical stage biotechnology company developing novel therapies for cardiovascular and metabolic aging, today announced its participation at the 36th Annual Oppenheimer Life Sciences...Vasa Therapeutics Granted FDA Fast Track Designation for VS-041, a Novel Investigational Treatment of Heart Failure with Preserved Ejection Fraction (HFpEF)
Designation underscores the potential for VS-041 to address a significant unmet medical need and potentially improve diagnosis by utilizing a serum biomarker VS-041 is being evaluated in a Phase 1c study of participants with HFpEF and elevated serum endotrophin ENCINITAS, Calif., and...
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Vasa Therapeutics
Sign Up For FreeTo access detailed company insights
Based out of Encinitas, Vasa Therapeutics, is a biopharmaceutical company with a focus on cardiovascular aging.... Read More
